APA (7th ed.) Citation

J, S., SA, F., D, N., K, P., AM, P., R, P., . . . MM, R. (2026). GLP-1 receptor agonist medications for weight loss: Sociodemographic patterns of awareness, use, and access in a U.S. national cohort. Annals of epidemiology, 122, 110151. https://doi.org/10.1016/j.annepidem.2026.110151

Chicago Style (17th ed.) Citation

J, Sanborn, Fleary SA, Nash D, Penrose K, Parcesepe AM, Piltch-Loeb R, Nuñez J, Shen Y, and Robertson MM. "GLP-1 Receptor Agonist Medications for Weight Loss: Sociodemographic Patterns of Awareness, Use, and Access in a U.S. National Cohort." Annals of Epidemiology 122 (2026): 110151. https://doi.org/10.1016/j.annepidem.2026.110151.

MLA (9th ed.) Citation

J, Sanborn, et al. "GLP-1 Receptor Agonist Medications for Weight Loss: Sociodemographic Patterns of Awareness, Use, and Access in a U.S. National Cohort." Annals of Epidemiology, vol. 122, 2026, p. 110151, https://doi.org/10.1016/j.annepidem.2026.110151.